Key result
Surgical excision of cardiac myxomas carries ~10% hospital mortality with no recurrences among survivors.
Why the study?
Does surgical excision with cardiopulmonary bypass improve symptoms and prevent recurrence in patients with cardiac myxomas?
Population
50 patients with cardiac myxoma confirmed by echocardiography, mean age 55.2 years, 17 men and 33 women.
Design
Case_series
Follow-up
mean 76.4 (range 1-241) months
Authors
Loading...
Supports surgical excision for cardiac myxomas with low recurrence; leaves open questions on generalizability and risk stratification in larger cohorts.
Observational (n=50)
Does surgical excision with cardiopulmonary bypass improve symptoms and prevent recurrence in patients with cardiac myxomas?
Surgical excision of cardiac myxomas is curative, providing excellent long-term survival and symptomatic improvement with no observed recurrences.
Lukács et al. (1997) conducted an observational in Cardiac myxomas (n=50). Surgical excision was evaluated on Hospital mortality rate. Surgical excision of cardiac myxomas resulted in a 10% hospital mortality rate, with no recurrences observed among survivors over a mean follow-up of 76.4 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: